Results 161 to 170 of about 89,708 (258)

HPV awareness and anal cancer prevention among sexual minority men living with HIV in Nigeria: insights from an affirming clinical setting. [PDF]

Sex Health
Volpi CR, Chama J, Adebiyi R, Aigoro JA, Jibrin Bawa Y, Kolawole KE, Ononaku U, Ayuba N, Shutt A, Aka A, Goldstone SE, Dakum P, Palefsky JM, Adebajo S, Tobin KE, Nowak RG.   +15 more
europepmc   +1 more source

Unveiling a New Link: Cholesterol Deficiency in Smith–Lemli–Opitz and Niemann–Pick C as a Driver of Ciliopathies

American Journal of Medical Genetics Part A, Volume 200, Issue 6, Page 1179-1191, June 2026.
ABSTRACT The ciliopathies are a group of genetic disorders caused by defective function of either the primary cilia (a large number) or the motile cilia (a much smaller number). These have been defined as diseases with mutations in genes encoding individual ciliary or cilia‐associated proteins.
Robert P. Erickson, Maria Teresa Fiorenza   +1 more
wiley   +1 more source

Immunodeficiency, HIV Viremia, and Incident Anal Cancer Among People With HIV in South Africa. [PDF]

Open Forum Infect Dis
Fernández Villalobos NV, Ruffieux Y, Chinogurei C, Haas AD, Low N, Egger M, Noble J, Folb N, Maartens G, Rohner E.   +9 more
europepmc   +1 more source

Social and Anxiety‐Like Behaviors Are Affected in Juvenile Mice With Gli2+/− but Not Gli3+/𝛥699 Genetic Modifications

Brain and Behavior, Volume 16, Issue 6, June 2026.
Across Gli3+/Δ699, Gli2+/−, and combined Gli2+/−;Gli3+/Δ699 mice (males and females, with wild‐type controls), GLI2 and GLI3 differentially regulate anogenital distance and juvenile behavior, with amplified effects under combined disruption, whereas circulating steroids and sexually dimorphic nucleus area remain unchanged. Created in BioRender. Niepsuj,
Thomas Niepsuj, Rithika Nurani, Leykza Carreras‐Simons, Wade Bushman, Joan S. Jorgensen, Walid A. Farhat, Anthony P. Auger   +6 more
wiley   +1 more source

Diagnostic and Therapeutic Impact of FDG-PET/CT Following MRI Staging in Anal Cancer: A Systematic Review and Meta-Analysis. [PDF]

J Med Imaging Radiat Oncol
Temperley HC, Bell JM, Deshwal A, Qian W, Cuddihy TO, Mac Curtain BM, O'Sullivan NJ, Sheahan KP, McCormick PH, Corr A, Sheehy N, Meaney JFM, Kelly ME.   +12 more
europepmc   +1 more source

Changes in Distress Screening and Information Reception Among Cancer Patients Following a Training for Oncology Nursing Staff: A Pilot Study

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background At least half of all cancer patients suffer from significant psychological distress, yet despite well‐validated screening procedures, distress often goes unrecognized or untreated. For this reason, a special training (OptiScreen‐Training) on this topic has been developed for oncology nurses and carried out on three visceral oncology
Lara Dreismann, Tanja Zimmermann
wiley   +1 more source

Inguinal CTV contouring in anal cancer: comparative validation of inguinal lymph nodes contouring guidelines and implications for consensus. [PDF]

Clin Transl Radiat Oncol
De Luca V, Manfrida S, Barogi N, De Giacomo F, Rinaldi RM, Fionda B, Bertolini R, Chiloiro G, Autorino R, Macchia G, Dinapoli N, L Hallemeier C, Garda AE, Gambacorta MA.   +13 more
europepmc   +1 more source

Safety and Tolerability of Different Total Neoadjuvant Therapies in Patients With Locally Advanced Rectal Cancer

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background Total neoadjuvant therapy (TNT) is the standard treatment for locally advanced rectal cancer (LARC). Few studies have focused on the toxicity of TNT. Moreover, the differences in safety and tolerability between radiotherapy‐first and chemotherapy‐first strategies remain unclear.
Shohei Udagawa, Hiroki Osumi, Senzo Taguchi, Tatsuki Noguchi, Takashi Sakamoto, Shimpei Matsui, Toshiki Mukai, Tomohiro Yamaguchi, Shota Fukuoka, Koichiro Yoshino, Keitaro Shimozaki, Takeru Wakatsuki, Mariko Ogura, Akira Ooki, Keisho Chin, Kensei Yamaguchi, Takashi Akiyoshi, Eiji Shinozaki   +17 more
wiley   +1 more source

Personalising anal cancer radiotherapy dose (PLATO): protocol for a multicentre integrated platform trial. [PDF]

BMJ Open
Frood R, Gilbert A, Gilbert D, Abbott NL, Richman SD, Goh V, Rao S, Webster J, Smith A, Copeland J, Ruddock SP, Berkman L, Muirhead R, Renehan AG, Harrison M, Adams R, Hawkins M, Brown S, Sebag-Montefiore D.   +18 more
europepmc   +1 more source

Analysis of Treatment Patterns for Mucosal Melanoma Using Real‐World Data in the SEER‐Medicare–Linked Database

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background Mucosal melanoma (MM) is a rare, aggressive disease, often diagnosed late, and associated with poor survival. Surgical resection is the main potential curative option, but anatomical complexity limits feasibility, and real‐world evidence on treatment patterns remains scarce.
Marjan Zakeri, Samuel Wagner, Xianxin Zhu, Onur Baser   +3 more
wiley   +1 more source